Navigation Links
Vasogen Announces First Quarter 2009 Results

Company and our business can be found in the "Risk Factors" section of our Annual Information Form and Form 20-F for the year ended November 30, 2008, as well as in our other public filings, including our Management's Discussion and Analysis for the period ended February 28, 2009. The forward-looking statements are made as of the date hereof, and we disclaim any intention and have no obligation or responsibility, except as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

The unaudited interim consolidated financial statements, accompanying notes to the unaudited interim consolidated financial statements, and Management's Discussion and Analysis for the three months ended February 28, 2009, will be accessible on Vasogen's Website at and will be available on SEDAR and EDGAR.

                 Summary financial tables are provided below.


    Interim Consolidated Balance Sheets
    (In thousands of Canadian dollars)

                                                  February 28,   November 30,
                                                         2009           2008
    Current assets:
      Cash and cash equivalents                  $      7,333   $      8,556
      Tax credits recoverable                             383            582
      Prepaid expenses and deposits                        64            188
                                                        7,780          9,326

    Property an
SOURCE Vasogen Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vasogen Announces 2008 Year-End Results
2. Vasogen Announces Sale of Patent Application and Provides Corporate Update
3. Vasogen Complies with NASDAQ Marketplace Rule 4350(c)(1)
4. Vasogen Provides Corporate Update
5. Vasogen Announces Third Quarter 2008 Results
6. Vasogen Announces Second Quarter 2008 Results
7. Vasogen Provides Corporate Update
8. Vasogen to Webcast Presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference
9. Vasogen Receives NASDAQ Notification Related to Minimum Bid Price
10. Vasogen Announces Implementation of Strategic Restructuring Plan
11. Vasogen Announces First Quarter 2008 Results
Post Your Comments:
(Date:10/22/2014)... 22, 2014 Research and Markets ... "Global DNA Diagnostics Market (Product types, Application, Technology, ... Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, ... report to their offering. This ... techniques, end users and Geography) Global Size, Industry ...
(Date:10/22/2014)... Shimadzu Scientific Instruments introduces its Open Solution QuantAnalytics(TM) ... management and clinical markets. The software increases the speed ... users to highlight and review results that are of ... to filter results by group or based on a ... need to sift through analytes of no interest. In ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Grace Century, ... and healthcare projects, announces the addition of Dr. ... to its advisory team. Dr. Siddiqui will provide further ... , A graduate of University College Medical School ... degreed in medicine in 2001. With further certification as ...
(Date:10/22/2014)... 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") ... for its Oral Amphotericin B program.  The company ... vitro work involving samples from HIV/AIDS patients ... complete pre clinical studies and regulatory filings to ... trial, utilizing approximately $700,000 of funding and technological ...
Breaking Biology Technology:Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 2Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 3Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3
... as a way to, protect the lives of the nation,s ... ... Poisoning, IRVINE, Calif., Feb. 19 Masimo (Nasdaq:,MASI), the inventor of ... the National Fire Protection,Association (NFPA) has included Carbon Monoxide (CO) screening by ...
... CAMBRIDGE, Mass.--MIT researchers have explained why two mutations in ... transmission in humans during the 1918 pandemic outbreak that ... showed that the 1918 influenza strain developed two mutations ... it to bind tightly to receptors in the human ...
... PHOENIX, Feb. 18 First Choice Professionals, LLC.,today ... expanding,Applications Services business unit. Mark will join FCP ... Mark brings thirteen years of Healthcare IT thought ... was responsible for the,Management of systems support at ...
Cached Biology Technology:National Fire Protection Association (NFPA) Sets New National Standard for CO Screening by Pulse CO-Oximetry(TM) 2National Fire Protection Association (NFPA) Sets New National Standard for CO Screening by Pulse CO-Oximetry(TM) 3National Fire Protection Association (NFPA) Sets New National Standard for CO Screening by Pulse CO-Oximetry(TM) 4MIT explains spread of 1918 flu 2FCP Welcomes Mark Scherling 2
(Date:10/18/2014)... and stress-related psychiatric disorders are associated with ... molecular mechanisms underlying this relation are unknown. ... development of targeted preventive strategies and new ... This work is presented at the European ... an international group of researchers from Germany ...
(Date:10/17/2014)... Copenhagen have shown for the first time how bacteria ... patients, giving them the opportunity to get tremendous insights ... The study also discovered the bacterial growth in chronic ... or slowed down by the immune cells. The researchers ... helped "suffocate" the bacteria, forcing the bacteria to switch ...
(Date:10/16/2014)... thinking on how the bowel lining develops and, in ... cancer starts. , The researchers produced evidence that stem ... that are a feature of the bowel lining, and ... development, a controversial finding as scientists are still divided ... technologies, Dr Chin Wee Tan and Professor Tony Burgess ...
Breaking Biology News(10 mins):Researchers find why depression and aging linked to increased disease risk 2Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2Cryptic clues drive new theory of bowel cancer development 2
... been described as "molecular switches" and play a role ... and multiple other common cellular functions. Understanding ... cellular mechanisms related to cancer, which is fundamentally a ... rapidly, multiply and migrate into inappropriate places in the ...
... pain (or lumbago) is a common ailment often triggered by something ... to remedy the situation? An exercise machine designed specifically for back ... in the Journal of the American College of Sports Medicine ... help the development and endurance of back muscles, you must focus ...
... his groundbreaking research focusing on population biology and ecology ... researcher Dr. David Secor has been awarded the University ... for Excellence. As a fisheries biologist, a large ... that often have management conflicts: striped bass, bluefin tuna, ...
Cached Biology News:Research pinpoints action of protein linked to key molecular switch 2Exercise therapy for low back pain 2UMCES fisheries biologist Dr. David Secor receives USM Regent's Faculty Award for research 2
... Human Cytokeratin TYPE II Reacts with ... Including epidermal cell keratin of 86 and ... 67kD. Broad keratin reactivity is found on ... Immunogen: Human epidermal cells ...
... CHEMICON XpressPack™ Colorimetric Detection System is intended ... amplified DNA generated by an in-house validated ... selected target of interest. • ... System is a hybridization capture assay designed ...
Mouse Anti-Human Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 (KIR2DL4 Monoclonal Antibody Family: New...
Polymerase (RNA) II (DNA directed) polypeptide L...
Biology Products: